1 / 15

Case Study: Weird Wonderful Walter

Case Study: Weird Wonderful Walter. Jayanna Slayten, MS, MT(ASCP)SBB Manager, IBC-IRL and SBB Program Education Coordinator Indiana Blood Center. Case History. Patient History Mr. Walter Wright - 80 year old Male Diagnosed with anemia Patient had hip surgery in July 2009

bridgit
Download Presentation

Case Study: Weird Wonderful Walter

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case Study: Weird WonderfulWalter Jayanna Slayten, MS, MT(ASCP)SBB Manager, IBC-IRL and SBB Program Education Coordinator Indiana Blood Center

  2. Case History • Patient History • Mr. Walter Wright - 80 year old Male • Diagnosed with anemia • Patient had hip surgery in July 2009 • Has been anemic for the last 6 months • Current values have been 7.0-9.5 g/dL • History of transfusion • July 2009 • At that time, patient had a cold reactive antibody that “prewarmed” away

  3. Initial Blood Bank Testing • Sample sent to lab • ABO/RH: A, D Positive • DAT: Polyspecific = 3+ • Antibody Screen: 4+ with all cells by Echo • Autocontrol (AC): Positive

  4. Investigation • Results • A, D Positive • DAT Positive • Panel testing • PEG-AHG • Ortho Gel

  5. Panel Testing

  6. Eluate Testing

  7. Further Investigation • Results (continued) • Full phenotype: • R1 R1 (D+C+E-c-e+) • K-; Fy(a+b+); Jk(a+b+); • M+S-s+, A1+, Le(a-b-), P1- • Tested phenotypically similar cells • Reactive by PEG-AHG (1+) • Reactive by Gel (2+) • Reactive with the eluate (3+) E c K S

  8. Confusion and Delay!! • Possibilities to consider… • Transfusion Reaction? • The patient has not been recently transfused • Autoantibody • All panel cells reactive • DAT positive, eluate is panreactive • Pursue autoadsorption • Prove autoantibody • Exclude any underlying alloantibodies.

  9. Panel Testing

  10. Initial Conclusions • Autoantibody • Patient’s autoantibody is not removed by a 4x autoadsorption? • What about provision of blood?

  11. Additional Testing • Started alloadsorption • Same results as autoadsorption! • 4+ with all cells….. • Completed Crossmatches Matched LISS-AHG • Unit 1 Gp A+ E-c-K-S- Compatible! • Unit 2 Gp A+ E-c-K-S- Compatible ! • Unit 3 Gp A+ E-c-K-S Compatible !

  12. Gp A Panel Testing

  13. Further Investigation • Autoantibody • Verified auto with positive DAT and eluate • Serum reactivity in PEG-AHG and LISS-AHG consistent with autoantibody • Is this a preference for ABO specific cells? • Repeat panel testing found • Group O panel washed x 1 = demonstrated anti-c • This disproved a preference for ABO cells (rare)

  14. Conclusions • Autoantibody reactivity in this case was enhanced when tested with • Reagent red cells (re-suspended in diluent) • Autoantibody not detected when tested with washed cells (donor or panel)

  15. Conclusion • The patient’s sample demonstrated • Anti-c • Warm autoantibody • This is an atypical presentation of an autoantibody……… • Patient received xm compatible E-c-K-S- units

More Related